Cytk earnings
WebFeb 22, 2024 · Cytokinetics (CYTK) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ... WebThe Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Cytk earnings
Did you know?
WebThe technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a … WebJun-24-22 08:44AM. Shareholders have faith in loss-making Cytokinetics (NASDAQ:CYTK) as stock climbs 20% in past week, taking three-year gain to 329%. Simply Wall St. 07:30AM. Cytokinetics Announces Date for FDA Advisory Committee Meeting to Review New Drug Application for Omecamtiv Mecarbil. GlobeNewswire.
WebMay 7, 2024 · Cytokinetics Inc (CYTK-0.65%) Q1 2024 Earnings Call May 6, 2024, 4:00 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good afternoon, and ... WebApr 10, 2024 · Key profitability statistics from the latest earnings report; CYTK income statement (TTM) Revenue: US$94.59m: Cost of Revenue: US$240.81m: Gross Profit-US$146.22m: Other Expenses: US$242.73m: Earnings-US$388.95m: Last Reported Earnings. Dec 31, 2024. Next Earnings Date. n/a. Earnings per share (EPS)-4.07: …
WebApr 13, 2024 · Analyst price target for CYTK is US$60.06, which is 58% above our fair value estimate. ... Debt is well covered by earnings. Weakness. Shareholders have been … WebCytokinetics (CYTK) delivered earnings and revenue surprises of -18.85% and 73.77%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? CYTK : 37.50 (+6.56%) LQDA : 7.00 (+1.30%) Cytokinetics: Q4 Earnings Snapshot AP - Wed Mar 1, 3:34PM CST Cytokinetics: Q4 Earnings Snapshot
WebApr 10, 2024 · In the past 30 days, estimates for Novo Nordisk’s 2024 earnings per share have risen from $4.20 to $4.43 and estimates for 2024 have gone up by 29 cents to $5.19.
WebApr 12, 2024 · Cytokinetics (NASDAQ:CYTK – Get Rating) last posted its earnings results on Wednesday, March 1st. The biopharmaceutical company reported ($1.45) earnings per share (EPS) for the quarter, missing ... how do statins work to control cholesterolWeb18 hours ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Cytokinetics (CYTK) how do statistics persuadeWebApr 6, 2024 · Cytokinetics, Incorporated (CYTK) latest earnings report: revenue, EPS, surprise, history, news and analysis. how do statistics persuade the readerWeb12 hours ago · Cytokinetics (CYTK) In a report released yesterday, Madhu Kumar from Goldman Sachs maintained a Buy rating on Cytokinetics. The company’s shares closed … how much should a contractor charge for laborWebApr 10, 2024 · Cytokinetics (CYTK) ... In the past 30 days, estimates for Novo Nordisk’s 2024 earnings per share have risen from $4.20 to $4.43 and estimates for 2024 have gone up by 29 cents to $5.19. how do statins work pathophysiologyWebCytokinetics (CYTK) will release its next earnings report on May 11, 2024. In the last quarter Cytokinetics reported -$1.206 EPS in relation to -$1.45 expected by the market. how much should a coo makeWebMar 2, 2024 · Press Release. EPS of -$1.45 misses by $0.24 Revenue of $1.96M (-96.48% Y/Y) misses by $4.51M. Cytokinetics, Incorporated ( NASDAQ: CYTK) Q4 2024 … how do statins works